Immunological cure of HBV infection
- PMID: 30600480
- DOI: 10.1007/s12072-018-9912-8
Immunological cure of HBV infection
Abstract
Chronic hepatitis B virus (HBV) infection is a major global health burden and cure is rarely achieved by current antiviral therapies. Therefore, there is an urgent need for new therapeutic options. Immune modulation with the goal to restore dysfunctional HBV-specific immunity is an interesting target for new therapeutic strategies. Based on the current evidence on immunology in resolving and persistent HBV infection, we will review the growing field of immunotherapeutic approaches for treatment of chronic HBV infection. We will also discuss the challenge of a heterogeneous patient population and personalized treatment as a possible key factor of success.
Keywords: Adaptive immunity; CD4+ T-lymphocytes; CD8+ T-lymphocytes; Hepatitis B; Immunotherapy.
Similar articles
-
Immunotherapy and therapeutic vaccines for chronic HBV infection.Curr Opin Virol. 2021 Dec;51:149-157. doi: 10.1016/j.coviro.2021.10.002. Epub 2021 Oct 26. Curr Opin Virol. 2021. PMID: 34710645 Review.
-
Hepatitis B virus: from immunobiology to immunotherapy.Clin Sci (Lond). 2013 Jan;124(2):77-85. doi: 10.1042/CS20120169. Clin Sci (Lond). 2013. PMID: 23013042 Review.
-
Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.Front Immunol. 2020 Feb 7;10:3127. doi: 10.3389/fimmu.2019.03127. eCollection 2019. Front Immunol. 2020. PMID: 32117201 Free PMC article. Review.
-
Heterogeneity of HBV-Specific CD8+ T-Cell Failure: Implications for Immunotherapy.Front Immunol. 2019 Sep 20;10:2240. doi: 10.3389/fimmu.2019.02240. eCollection 2019. Front Immunol. 2019. PMID: 31620140 Free PMC article. Review.
-
Advances in therapeutics for chronic hepatitis B.Hepatol Int. 2016 Mar;10(2):277-85. doi: 10.1007/s12072-015-9661-x. Epub 2015 Sep 12. Hepatol Int. 2016. PMID: 26363922 Review.
Cited by
-
Host Genetic Determinants of Hepatitis B Virus Infection.Front Genet. 2019 Aug 13;10:696. doi: 10.3389/fgene.2019.00696. eCollection 2019. Front Genet. 2019. PMID: 31475028 Free PMC article. Review.
-
Designing the next-generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures.Clin Transl Immunology. 2021 Jan 15;10(1):e1232. doi: 10.1002/cti2.1232. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33489122 Free PMC article. Review.
-
A bioinformatics investigation into molecular mechanism of Yinzhihuang granules for treating hepatitis B by network pharmacology and molecular docking verification.Sci Rep. 2020 Jul 10;10(1):11448. doi: 10.1038/s41598-020-68224-7. Sci Rep. 2020. PMID: 32651427 Free PMC article.
-
Critical Updates on Chronic Hepatitis B Virus Infection in 2021.Cureus. 2021 Oct 30;13(10):e19152. doi: 10.7759/cureus.19152. eCollection 2021 Oct. Cureus. 2021. PMID: 34733599 Free PMC article. Review.
-
Immune Checkpoint Molecules Expressed on CD4+ T Cell Subsets in Chronic Asymptomatic Hepatitis B Virus Carriers With Hepatitis B e Antigen-Negative.Front Microbiol. 2022 Apr 27;13:887408. doi: 10.3389/fmicb.2022.887408. eCollection 2022. Front Microbiol. 2022. PMID: 35572697 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials